CORDIS
EU research results

CORDIS

English EN

Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome

Periodic Reporting for period 1 - CureCN (Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome)

Reporting period: 2018-01-01 to 2019-06-30

CureCN project logo

Project information

Grant agreement ID: 755225

Status

Ongoing project

  • Start date

    1 January 2018

  • End date

    31 December 2022

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 6 249 103,75

  • EU contribution

    € 6 249 103,75

Coordinated by:

ASSOCIATION GENETHON